Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 19 |
NetGPI | no | yes: 0, no: 20 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005759 | mitochondrial matrix | 5 | 21 |
GO:0031974 | membrane-enclosed lumen | 2 | 21 |
GO:0043233 | organelle lumen | 3 | 21 |
GO:0070013 | intracellular organelle lumen | 4 | 21 |
GO:0110165 | cellular anatomical entity | 1 | 21 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 70 | 74 | PF00656 | 0.755 |
CLV_C14_Caspase3-7 | 9 | 13 | PF00656 | 0.568 |
CLV_NRD_NRD_1 | 20 | 22 | PF00675 | 0.686 |
CLV_NRD_NRD_1 | 45 | 47 | PF00675 | 0.653 |
CLV_PCSK_KEX2_1 | 129 | 131 | PF00082 | 0.331 |
CLV_PCSK_KEX2_1 | 156 | 158 | PF00082 | 0.401 |
CLV_PCSK_KEX2_1 | 20 | 22 | PF00082 | 0.683 |
CLV_PCSK_PC1ET2_1 | 129 | 131 | PF00082 | 0.368 |
CLV_PCSK_PC1ET2_1 | 156 | 158 | PF00082 | 0.401 |
DOC_CKS1_1 | 35 | 40 | PF01111 | 0.799 |
DOC_PP2B_LxvP_1 | 3 | 6 | PF13499 | 0.595 |
DOC_USP7_MATH_1 | 6 | 10 | PF00917 | 0.749 |
DOC_WW_Pin1_4 | 34 | 39 | PF00397 | 0.801 |
LIG_14-3-3_CanoR_1 | 111 | 118 | PF00244 | 0.564 |
LIG_14-3-3_CanoR_1 | 8 | 15 | PF00244 | 0.543 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.504 |
LIG_CtBP_PxDLS_1 | 61 | 67 | PF00389 | 0.740 |
LIG_deltaCOP1_diTrp_1 | 180 | 189 | PF00928 | 0.513 |
LIG_FHA_1 | 133 | 139 | PF00498 | 0.597 |
LIG_FHA_1 | 35 | 41 | PF00498 | 0.544 |
LIG_FHA_1 | 50 | 56 | PF00498 | 0.728 |
LIG_FHA_2 | 120 | 126 | PF00498 | 0.510 |
LIG_FHA_2 | 150 | 156 | PF00498 | 0.503 |
LIG_FHA_2 | 17 | 23 | PF00498 | 0.636 |
LIG_FHA_2 | 68 | 74 | PF00498 | 0.728 |
LIG_GBD_Chelix_1 | 138 | 146 | PF00786 | 0.401 |
LIG_LIR_Apic_2 | 132 | 137 | PF02991 | 0.512 |
LIG_LIR_Gen_1 | 141 | 151 | PF02991 | 0.601 |
LIG_LIR_Gen_1 | 165 | 174 | PF02991 | 0.601 |
LIG_LIR_LC3C_4 | 62 | 66 | PF02991 | 0.747 |
LIG_LIR_Nem_3 | 141 | 147 | PF02991 | 0.545 |
LIG_LIR_Nem_3 | 165 | 169 | PF02991 | 0.585 |
LIG_LIR_Nem_3 | 81 | 86 | PF02991 | 0.526 |
LIG_LRP6_Inhibitor_1 | 105 | 111 | PF00058 | 0.401 |
LIG_PDZ_Class_2 | 186 | 191 | PF00595 | 0.523 |
LIG_PTB_Apo_2 | 106 | 113 | PF02174 | 0.559 |
LIG_SH2_CRK | 134 | 138 | PF00017 | 0.535 |
LIG_SH2_CRK | 144 | 148 | PF00017 | 0.535 |
LIG_SH2_NCK_1 | 113 | 117 | PF00017 | 0.602 |
LIG_SH2_STAP1 | 113 | 117 | PF00017 | 0.631 |
LIG_SH2_STAP1 | 170 | 174 | PF00017 | 0.526 |
LIG_SH2_STAP1 | 179 | 183 | PF00017 | 0.434 |
LIG_SH2_STAT3 | 85 | 88 | PF00017 | 0.601 |
LIG_SH2_STAT5 | 134 | 137 | PF00017 | 0.601 |
LIG_SH2_STAT5 | 153 | 156 | PF00017 | 0.513 |
LIG_SH2_STAT5 | 85 | 88 | PF00017 | 0.562 |
LIG_SH3_3 | 30 | 36 | PF00018 | 0.687 |
LIG_TRAF2_1 | 99 | 102 | PF00917 | 0.601 |
LIG_TYR_ITIM | 142 | 147 | PF00017 | 0.581 |
LIG_WRC_WIRS_1 | 169 | 174 | PF05994 | 0.601 |
MOD_CK2_1 | 119 | 125 | PF00069 | 0.536 |
MOD_CK2_1 | 149 | 155 | PF00069 | 0.568 |
MOD_CK2_1 | 16 | 22 | PF00069 | 0.583 |
MOD_CK2_1 | 96 | 102 | PF00069 | 0.588 |
MOD_GlcNHglycan | 121 | 125 | PF01048 | 0.357 |
MOD_GlcNHglycan | 8 | 11 | PF01048 | 0.588 |
MOD_GSK3_1 | 49 | 56 | PF00069 | 0.692 |
MOD_GSK3_1 | 67 | 74 | PF00069 | 0.755 |
MOD_NEK2_1 | 53 | 58 | PF00069 | 0.653 |
MOD_PIKK_1 | 84 | 90 | PF00454 | 0.616 |
MOD_PKA_2 | 66 | 72 | PF00069 | 0.734 |
MOD_Plk_1 | 96 | 102 | PF00069 | 0.575 |
MOD_Plk_4 | 149 | 155 | PF00069 | 0.527 |
MOD_Plk_4 | 168 | 174 | PF00069 | 0.540 |
MOD_ProDKin_1 | 34 | 40 | PF00069 | 0.803 |
MOD_SUMO_rev_2 | 155 | 163 | PF00179 | 0.601 |
TRG_DiLeu_BaEn_1 | 101 | 106 | PF01217 | 0.568 |
TRG_DiLeu_BaEn_1 | 60 | 65 | PF01217 | 0.735 |
TRG_ENDOCYTIC_2 | 144 | 147 | PF00928 | 0.581 |
TRG_Pf-PMV_PEXEL_1 | 21 | 25 | PF00026 | 0.717 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P990 | Leptomonas seymouri | 86% | 83% |
A0A0N1HS24 | Leptomonas seymouri | 24% | 75% |
A0A0S4ITN8 | Bodo saltans | 39% | 84% |
A0A0S4J7P7 | Bodo saltans | 30% | 100% |
A0A1X0NTH7 | Trypanosomatidae | 26% | 73% |
A0A1X0P207 | Trypanosomatidae | 48% | 86% |
A0A3Q8IBW7 | Leishmania donovani | 94% | 82% |
A0A3Q8IFM4 | Leishmania donovani | 28% | 75% |
A0A422P4Z7 | Trypanosoma rangeli | 43% | 85% |
A4HCI6 | Leishmania braziliensis | 28% | 100% |
A4I007 | Leishmania infantum | 28% | 75% |
A4I5C8 | Leishmania infantum | 94% | 94% |
C9ZQR0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 40% | 84% |
C9ZSQ9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 29% | 73% |
E9AVY0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 77% |
E9B0M6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 82% |
Q4Q7K6 | Leishmania major | 93% | 100% |
Q4QBJ9 | Leishmania major | 29% | 100% |
V5BDB3 | Trypanosoma cruzi | 26% | 73% |